【三花智控(02050.HK)、佰泽医疗(02609.HK)、药捷安康-B(02617.HK)已获接纳在中央结算系统内进

智通财经
20 Jun
【三花智控(02050.HK)、佰泽医疗(02609.HK)、药捷安康-B(02617.HK)已获接纳在中央结算系统内进行结算、交收及提存】智通财经APP获悉,6月19日,香港中央结算有限公司发布通告称,三花智控(02050.HK)、佰泽医疗(02609.HK)、药捷安康-B(02617.HK)已获接纳在中央结算系统内进行结算、交收及提存。自2025年6月20日起,该等证券在联交所的买卖将透过中央结算系统进行结算;并于2025年6月23日起透过中央结算系统自动以持续净额交收制度进行交收。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10